ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (600196 CH)

66
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
Refresh
04 Oct 2021 15:09

MicroPort MedBot Pre-IPO - Thoughts on Valuation

MicroPort MedBot (MM), a surgical robot company, aims to raise up to US$1bn in its Hong Kong IPO. It is a subsidiary of Microport Scientific (853...

Logo
366 Views
Share
02 Oct 2021 22:48

Kintor Pharmaceutical (9939 HK) – Dual Play on COVID and Solid Tumors

Kintor Pharma is set to fly high ahead of its first product launch in China for prostate cancer, which has high unmet medical need. COVID-19...

Logo
354 Views
Share
16 Sep 2021 09:02

Pre-IPO Jiangsu Recbio Technology - There Are Many Uncertainties

This article mainly analyzed Recbio Technology in terms of the vaccine industry characteristics, core product candidates (HPV vaccines, COVID-19...

Logo
238 Views
Share
bearishAIM Vaccine
15 Sep 2021 09:12

Pre-IPO AIM Vaccine - Insights on Key Products, Pipeline and Concerns

This article mainly analyzed AIM in terms of the vaccine industry characteristics, the key vaccine products (human rabies vaccine, recombinant HBV...

Logo
236 Views
Share
x